DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)

Information source: Jamaica Hospital Medical Center
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Schizophrenia OCD; Obsessive Compulsive Disorder

Intervention: Aripiprazole (Drug)

Phase: N/A

Status: Completed

Sponsored by: Jamaica Hospital Medical Center

Official(s) and/or principal investigator(s):
Isak Isakov, M.D., Principal Investigator, Affiliation: Jamaica Hospital Medical Center

Summary

To evaluate the effectiveness of flexible doses (15-30mg) of Aripiprazole in the treatment of patients with schizophrenia and co-morbid symptoms of OCD in the outpatient setting. The overall effectiveness of Aripiprazole will be evaluated by use of the Brief Psychiatric Rating Scale(BPRS), Yale-Brown OCD scale and Clinical Global Impression-Improvement(CGI-I) scale.

Clinical Details

Official title: "Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)".

Study design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: The overall effectiveness of Aripiprazole will be evaluated by use of the BPRS, Yale-Brown OCD scale and Clinical Global Impression-Improvement (CGI-I) scale, including efficacy in reduction of psychosis and obsessions.Improvements in YBOCS and BPRS scor

Secondary outcome: Physical Examination, Psychiatric evaluation with YBOCS, BPRS and CGI scales, EPS scale, routine hematology and chemistry tests, urinalysis,urine drug screening,urine pregnancy test, ECG recording

Detailed description: Symptoms of OCD is a rather common co-morbid condition in patients with Schizophrenia. Some studies suggest that obsessive-compulsive symptoms may be present in 7. 8-46% of schizophrenic patients and who seem to be poorly responsive to drug therapy. The serotonergic medications in combination with cognitive-behavioral therapy stil remain the preferred treatment for OCD symptoms. There are controversial data regarding effect of neuroleptics on symptoms of OCD. It was noted that the use of Risperdone, Quatiapine and Clozapine might aggravate OCD symptoms. Serotonin antagonism of these neuroleptics is believed to exacerbate obsessive-compulsive symptoms in schizophrenia. On the other hand, Pourovsky M. at(2000) reported three cases of Schizophrenia with symptoms of OCD successfully treated with Olanzapine. One of our patients with Schizophrenia and co-morbid symptoms of OCD who was unsuccessfully treated with various neuroleptics in combination with anti-obsessive agents,demonstrated significant improvement in both Schizophrenic and obsessive compulsive symptoms after she was switched to Aripiprazole. This result encouraged us to initiate pilot study of effectiveness of Aripiprazole in the treatment of specific population of schizophrenic patients with symptoms of OCD.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Man and Women 18-65 years of age.

- Patients who are capable of giving Informed Consent and fluent in English.

- Patients who have DSM IV -Diagnosis of schizophrenia with co-morbid OCD symptoms and

BPRS score averaging from mild to moderate (3-4).

- Patients whose obsessive symptoms are not optimally controlled and require a change

of treatment. YBOCS score of more than 16. Exclusion Criteria:

- Outside the age range of 18-65 years.

- Patients with current evidence(past three months) of substance abuse.

- Women of child bearing age who are unwilling to use acceptable methods of

contraception.

- Patients who have had recent treatment with long-acting antipsychotic.

- Patients who are suicidal or who have history of recent suicidal attempt.

- History of significant medical condition e. g. seizures, cardiovascular,

endocrine,gastrointestinal,renal or respiratory diseases.

Locations and Contacts

Jamaica Hospital Medical Center Department of Psychiatry, Jamaica, New York 11418, United States
Additional Information

Starting date: March 2005
Last updated: September 15, 2011

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017